Buglioni, S., Melucci, E., Sperati, F., Pallocca, M., Terrenato, I., De Nicola, F., . . . Maugeri-Saccà, M. (2018). The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1A mutations and ATM expression. Oncoimmunology.
Čikaški stil citiranjaBuglioni, Simonetta, et al. "The Clinical Significance of PD-L1 in Advanced Gastric Cancer Is Dependent On ARID1A Mutations and ATM Expression." Oncoimmunology 2018.
MLA način citiranjaBuglioni, Simonetta, et al. "The Clinical Significance of PD-L1 in Advanced Gastric Cancer Is Dependent On ARID1A Mutations and ATM Expression." Oncoimmunology 2018.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.